Lanean...
Access to orphan drugs in the Middle East: Challenge and perspective
An orphan drug is a drug developed specifically to treat a rare medical condition. With a combined population of less than 400 million, about 2.8 million patients are estimated to be suffering from a rare disease in the Middle East. Some disorders such as hemoglobinopathy, glucose-6-phosphate dehydr...
Gorde:
| Egile Nagusiak: | , , , |
|---|---|
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
International Research and Cooperation Association for Bio & Socio-Sciences Advancement
2012
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4204565/ https://ncbi.nlm.nih.gov/pubmed/25343087 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5582/irdr.2012.v1.4.139 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|